Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis

Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Alpha-fetoprotein (AFP) is still the only serum biomarker widely used in clinical settings. However, approximately 40% of HCC patients exhibit normal AFP levels, including very early HCC and AFP-negative HCC; for these patients, serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Huang, Xue-ying, Zheng, Su-jun, Liu, Ye-ying, Chen, Si-si, Ren, Feng, Lu, Jun, Duan, Zhong-ping, Liu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555665/
https://www.ncbi.nlm.nih.gov/pubmed/34722278
http://dx.doi.org/10.3389/fonc.2021.733680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555665/
https://www.ncbi.nlm.nih.gov/pubmed/34722278
http://dx.doi.org/10.3389/fonc.2021.733680

Ejemplares similares